Page last updated: 2024-10-31

mianserin and Breast Cancer

mianserin has been researched along with Breast Cancer in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
"The efficacy and safety of mianserin were studied in 55 depressed women with breast cancer (stage I or II and without known metastases), in a randomised, double-blind, six-week, placebo-controlled study."5.08Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin. ( van Heeringen, K; Zivkov, M, 1996)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Heeringen, K1
Zivkov, M1
Maguire, P1
Hopwood, P1
Tarrier, N1
Howell, T1

Trials

2 trials available for mianserin and Breast Cancer

ArticleYear
Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    The British journal of psychiatry : the journal of mental science, 1996, Volume: 169, Issue:4

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Breast Neoplasms; Depressive Disorder; Double

1996
Treatment of depression in cancer patients.
    Acta psychiatrica Scandinavica. Supplementum, 1985, Volume: 320

    Topics: Amitriptyline; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Depression; Fe

1985